Qube Research & Technologies (QRT)’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,654
Closed -$820K 3037
2021
Q1
$820K Buy
+13,654
New +$494K 0.01% 929

Qube Research & Technologies (QRT)'s PAND Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 13,654 shares — an estimated $820K sold.

Qube Research & Technologies (QRT) first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $820K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 13,654 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $820K.
  • Qube Research & Technologies (QRT) first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Pandion Therapeutics Inc. Common Stock position peaked at $820K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.